Seeing Is Believing
PTGX is currently covered by 7 analysts with an average price target of $41.59. This is a potential upside of $14.98 (56.29%) from yesterday's end of day stock price of $26.61.
Protagonist Therapeutics's activity chart (see below) currently has 60 price targets and 72 ratings on display. The stock rating distribution of PTGX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 48.41% with an average time for these price targets to be met of 248.86 days.
Highest price target for PTGX is $42, Lowest price target is $35, average price target is $41.59.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 06-Sep-2016.
Currently out of the existing stock ratings of PTGX, 25 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
38
$11.39 (42.80%)
38
1 months 12 days ago
5/17 (29.41%)
$7.88 (26.16%)
226
Buy
42
$15.39 (57.84%)
37
1 months 12 days ago
3/6 (50%)
$11.88 (39.44%)
211
Buy
37
$10.39 (39.05%)
34
1 months 26 days ago
0/2 (0%)
$6.57 (21.59%)
Buy
35
$8.39 (31.53%)
35
9 months 20 days ago
0/10 (0%)
$12.69 (56.88%)
Buy
41
$14.39 (54.08%)
45
9 months 20 days ago
0/3 (0%)
$18.69 (83.77%)
What is PTGX (Protagonist Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PTGX (Protagonist Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most bullish on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most reserved on PTGX (Protagonist Therapeutics)?